Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma

J Clin Exp Hematop. 2023;63(4):262-265. doi: 10.3960/jslrt.23043.NO ABSTRACTPMID:38148017 | PMC:PMC10861370 | DOI:10.3960/jslrt.23043

Source: Journal of Clinical and Experimental Hematopathology : JCEH - December 26, 2023 Category: Hematology Authors: Yasunobu Sekiguchi Hiroki Tsutsumi Ayumi Gomyo Masahisa Kudo Yoshie Iizaki Nobuo Maseki Machiko Kawamura Kazuhiko Kobayashi Yu Nishimura Hiroaki Kanda Hideaki Nitta Masaaki Noguchi Hirofumi Kobayashi Source Type: research